A. Cooper

954 total citations · 1 hit paper
20 papers, 709 citations indexed

About

A. Cooper is a scholar working on Oncology, Surgery and Sociology and Political Science. According to data from OpenAlex, A. Cooper has authored 20 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Surgery and 3 papers in Sociology and Political Science. Recurrent topics in A. Cooper's work include Cancer survivorship and care (6 papers), Lymphatic System and Diseases (5 papers) and Family Support in Illness (3 papers). A. Cooper is often cited by papers focused on Cancer survivorship and care (6 papers), Lymphatic System and Diseases (5 papers) and Family Support in Illness (3 papers). A. Cooper collaborates with scholars based in United States, United Kingdom and Germany. A. Cooper's co-authors include David C. Smith, A.V.M. Hughson, C S McArdle, Marc L. Citron, Louis S. Constine, Christine Miaskowski, Russell K. Portenoy, Christina Lacchetti, Paul A. Sloan and Éduardo Bruera and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Magnetic Resonance in Medicine.

In The Last Decade

A. Cooper

16 papers receiving 685 citations

Hit Papers

Management of Chronic Pain in Survivors of Adult Cancers:... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Cooper United States 10 357 246 223 211 119 20 709
D. Storey United Kingdom 12 541 1.5× 65 0.3× 143 0.6× 201 1.0× 48 0.4× 22 858
Eivor Alette Laugsand Norway 10 217 0.6× 107 0.4× 159 0.7× 145 0.7× 114 1.0× 14 531
Miep A. van der Drift Netherlands 14 279 0.8× 103 0.4× 59 0.3× 84 0.4× 195 1.6× 22 909
Marylin Dodd United States 9 190 0.5× 116 0.5× 87 0.4× 114 0.5× 108 0.9× 9 458
Alberto Sbanotto Italy 12 136 0.4× 213 0.9× 73 0.3× 175 0.8× 97 0.8× 22 472
Yoshinobu Matsuda Japan 14 291 0.8× 56 0.2× 254 1.1× 127 0.6× 39 0.3× 108 756
D. F. Cella United States 2 170 0.5× 61 0.2× 90 0.4× 89 0.4× 45 0.4× 3 456
Paul Coluzzi United States 11 105 0.3× 689 2.8× 153 0.7× 575 2.7× 268 2.3× 22 960
Lynn Palmer United States 11 148 0.4× 74 0.3× 333 1.5× 136 0.6× 119 1.0× 15 781
Ali Haider United States 14 91 0.3× 230 0.9× 218 1.0× 154 0.7× 127 1.1× 75 633

Countries citing papers authored by A. Cooper

Since Specialization
Citations

This map shows the geographic impact of A. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Cooper more than expected).

Fields of papers citing papers by A. Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Cooper. The network helps show where A. Cooper may publish in the future.

Co-authorship network of co-authors of A. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of A. Cooper. A scholar is included among the top collaborators of A. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Cooper. A. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, A., Michelle S. Ginsberg, Lynette M. Sholl, et al.. (2025). 233P: Chemo-immunotherapy for borderline resectable and unresectable NSCLC. Journal of Thoracic Oncology. 20(3). S148–S148.
2.
Donahue, Manus J., Paula M. C. Donahue, Chelsea Lee, et al.. (2023). In vivo lymph node CEST‐Dixon MRI in breast cancer patients with metastatic lymph node involvement. Magnetic Resonance in Medicine. 91(2). 670–680.
3.
Rockson, Stanley G., et al.. (2022). Safety and effectiveness of a novel nonpneumatic active compression device for treating breast cancer-related lymphedema: A multicenter randomized, crossover trial (NILE). Journal of Vascular Surgery Venous and Lymphatic Disorders. 10(6). 1359–1366.e1. 9 indexed citations
4.
Whitworth, Pat W., Chirag Shah, Frank A. Vicini, & A. Cooper. (2018). Preventing Breast Cancer-Related Lymphedema in High-Risk Patients: The Impact of a Structured Surveillance Protocol Using Bioimpedance Spectroscopy. Frontiers in Oncology. 8. 197–197. 25 indexed citations
5.
Whitworth, Pat W. & A. Cooper. (2017). Reducing the rate of chronic breast cancer related lymphedema through prospective surveillance monitoring using bioimpedance spectroscopy (BIS). European Journal of Surgical Oncology. 43(5). S33–S33. 1 indexed citations
6.
Whitworth, Pat W. & A. Cooper. (2017). Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy. The Breast Journal. 24(1). 62–65. 29 indexed citations
7.
Whitworth, Pat W., Chirag Shah, Frank A. Vicini, & A. Cooper. (2017). Reducing chronic breast cancer related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy (BIS).. Journal of Clinical Oncology. 35(15_suppl). 10117–10117. 1 indexed citations
8.
Paice, Judith A., Russell K. Portenoy, Christina Lacchetti, et al.. (2016). Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 34(27). 3325–3345. 398 indexed citations breakdown →
9.
Scott, James G., A. Cooper, Anne S. Reiner, et al.. (2010). Prognostic factors for glioblastoma (GBM) in individuals age 70 and older: A study of 446 patients from two tertiary centers.. Journal of Clinical Oncology. 28(15_suppl). 2034–2034.
10.
Cooper, A., et al.. (1999). AN EXAMINATION OF THE VOLUME-MORTALITY RELATIONSHIP FOR NEW YORK STATE TRAUMA CENTERS. 47(1). 209–209. 3 indexed citations
11.
Cooper, A. & Darrel Baumgardner. (1989). Meeting Review: Workshop on Airborne Instrumentation 19-21 October 1988. UCAR/NCAR. 1 indexed citations
12.
Cooper, A., et al.. (1989). Meeting Review the Second NCAR Research Aircraft Fleet Workshop. UCAR/NCAR. 1 indexed citations
13.
Hughson, A.V.M., A. Cooper, C S McArdle, & David C. Smith. (1988). Validity of the general health questionnaire and its subscales in patients receiving chemotherapy for early breast cancer. Journal of Psychosomatic Research. 32(4-5). 393–402. 24 indexed citations
14.
Hughson, A.V.M., A. Cooper, C S McArdle, & David C. Smith. (1988). Psychosocial consequences of mastectomy: Levels of morbidity and associated factors. Journal of Psychosomatic Research. 32(4-5). 383–391. 60 indexed citations
15.
Hughson, A.V.M., et al.. (1988). Psychosocial morbidity in patients awaiting breast biopsy. Journal of Psychosomatic Research. 32(2). 173–180. 50 indexed citations
16.
Hughson, A.V.M., A. Cooper, C S McArdle, & David C. Smith. (1987). Psychosocial effects of radiotherapy after mastectomy.. BMJ. 294(6586). 1515–1518. 33 indexed citations
17.
Hughson, A.V.M., A. Cooper, C S McArdle, & David C. Smith. (1986). Psychological impact of adjuvant chemotherapy in the first two years after mastectomy.. BMJ. 293(6557). 1268–1271. 49 indexed citations
18.
Cooper, A.. (1982). Settlement of Medical Liability Lawsuits Without Physician's Consent. JAMA. 248(16). 1980–1980. 2 indexed citations
19.
McArdle, C S, et al.. (1981). The social, emotional and financial implications of adjuvant chemotherapy in breast cancer. British journal of surgery. 68(4). 261–264. 23 indexed citations
20.
Cooper, A.. (1966). Expanded Ebonite for Low Temperature Insulation. Journal of Cellular Plastics. 2(3). 166–171.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026